• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,340.15
  • 0.83 %
  • $314.05
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Kodiak Sciences Inc. (KOD) Stock Price, News & Analysis

Kodiak Sciences Inc. (KOD) Stock Price, News & Analysis

Currency in USD Disclaimer

$5.92

$0.13

(2.16%)

Day's range
$5.66
Day's range
$6.03
50-day range
$2.33
Day's range
$6.03
  • Country: US
  • ISIN: US50015M1099
52 wk range
$2.19
Day's range
$7.77
  • CEO: Dr. Victor Perlroth M.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -5.00
  • Piotroski Score 2.00
  • Grade Neutral
  • Symbol (KOD)
  • Company Kodiak Sciences Inc.
  • Price $5.92
  • Changes Percentage (2.16%)
  • Change $0.13
  • Day Low $5.66
  • Day High $6.03
  • Year High $7.77

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naĂŻve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/26/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $15.00
  • High Stock Price Target $114.00
  • Low Stock Price Target $2.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$4.44
  • Trailing P/E Ratio -0.65
  • Forward P/E Ratio -0.65
  • P/E Growth -0.65
  • Net Income $-260,491,000

Income Statement

Quarterly

Annual

Latest News of KOD

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Kodiak Sciences Inc. Frequently Asked Questions

  • What were the earnings of KOD in the last quarter?

    In the last quarter Kodiak Sciences Inc. earnings were on Wednesday, August, 14th. The Kodiak Sciences Inc. maker reported -$0.86 EPS for the quarter, beating analysts' consensus estimates of -$0.87 by $0.01.

  • What is the Kodiak Sciences Inc. stock price today?

    Today's price of Kodiak Sciences Inc. is $5.92 — it has increased by +2.16% in the past 24 hours. Watch Kodiak Sciences Inc. stock price performance more closely on the chart.

  • Does Kodiak Sciences Inc. release reports?

    Yes, you can track Kodiak Sciences Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Kodiak Sciences Inc. stock forecast?

    Watch the Kodiak Sciences Inc. chart and read a more detailed Kodiak Sciences Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Kodiak Sciences Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Kodiak Sciences Inc. stock ticker.

  • How to buy Kodiak Sciences Inc. stocks?

    Like other stocks, KOD shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Kodiak Sciences Inc.'s EBITDA?

    Kodiak Sciences Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Kodiak Sciences Inc.’s financial statements.

  • What is the Kodiak Sciences Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Kodiak Sciences Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Kodiak Sciences Inc.'s financials relevant news, and technical analysis. Kodiak Sciences Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Kodiak Sciences Inc. stock currently indicates a “sell” signal. For more insights, review Kodiak Sciences Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
Ă—
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

Ă—

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

Ă—

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.